Literature DB >> 10515336

Predictors of breast cancer in women recalled following screening.

M A Price1, C C Tennant, R C Smith, S J Kennedy, P N Butow, M B Kossoff, S M Dunn.   

Abstract

BACKGROUND: Established risk factors are associated with between 25 and 56% of breast cancer cases, but the relative importance and relevance to different age groups is unclear.
METHODS: This case-control study examines established risk factors in 298 women with breast cancer and 1926 women without breast cancer aged 40-87 who were recalled for assessment following routine mammography.
RESULTS: The cancer group were significantly older than the non-cancer group (F1,222 = 107.6; P < 0.0001). Postmenopausal obesity increased the odds of developing breast cancer (OR: 2.35; CI: 1.33-4.16). The breast cancer group were more likely to have used oral contraceptives (OR: 1.50; CI: 1.09-2.05), and women who used contraceptives for more than 10 years in total were at the highest risk (OR: 1.73; CI: 1.13-2.65). Daily consumption of alcohol was also associated with increased risk of developing breast cancer (OR: 1.62; CI: 1.13-2.33). Reproductive factors and a family history of breast cancer did not affect the odds of developing breast cancer and the reasons for these findings are explored.
CONCLUSIONS: Results suggest that the effects of weight reduction in reducing postmenopausal breast cancer risk should be assessed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515336     DOI: 10.1046/j.1440-1622.1999.01655.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  1 in total

Review 1.  Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010.

Authors:  Wiesław Kanadys; Agnieszka Barańska; Maria Malm; Agata Błaszczuk; Małgorzata Polz-Dacewicz; Mariola Janiszewska; Marian Jędrych
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.